We see these side effects for a few reasons: GLP-1s delay how fast our stomachs empty which can lead to bloating, fullness and nausea
Strong indicators that you are ready for the next dose step include: GI side effects have fully resolved at the current dose Appetite suppression has stabilized (not increasing or decreasing week to week) Weight loss has slowed or plateaued at the current dose Energy levels are stable and consistent Sleep quality has returned to baseline Indicators that you should hold at the current dose for another cycle include: Persistent nausea beyond the first week at the current dose Digestive issues that have not resolved Weight loss is still progressing well (no need to increase if current dose is working) Energy levels are still adjusting Any concerning symptoms that need medical evaluation The tracking data also helps identify your optimal maintenance dose
The outcomes of these studies mainly concern weight loss and the improvement of anthropometric parameters
Timing: 1520 minutes before the meal you want to blunt
GLP-1 agonists work by mimicking a naturally occurring hormone that regulates blood glucose levels, enhances insulin secretion when blood sugar is elevated, suppresses glucagon release, and slows gastric emptying
And some research has raised, if not red flags, perhaps a few yellowish ones
